BQ-788
BQ-788
BQ-788 (pronunciation: B-Q-Seven-Eight-Eight) is a specific endothelin receptor antagonist that has been extensively used in scientific research to help understand the endothelin system. It is a compound that selectively inhibits the endothelin B receptor (ETB).
Etymology
The term "BQ-788" does not have a known etymology. It is a systematic name given to the compound by the researchers who first synthesized it.
Function
BQ-788 has a high affinity for the ETB receptor, and it works by blocking the action of endothelin-1, a potent vasoconstrictor. This makes BQ-788 a valuable tool in the study of the endothelin system, particularly in relation to cardiovascular physiology and pathophysiology.
Related Terms
- Endothelin receptor antagonist: A type of drug that blocks the effects of endothelin, a potent vasoconstrictor.
- Endothelin B receptor (ETB): One of the receptors that endothelin binds to, causing vasoconstriction.
- Endothelin-1: A potent vasoconstrictor peptide produced by vascular endothelial cells.
See Also
External links
- Medical encyclopedia article on BQ-788
- Wikipedia's article - BQ-788
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski